Innopharma Education Revenue and Competitors
Estimated Revenue & Valuation
- Innopharma Education's estimated annual revenue is currently $29.9M per year.
- Innopharma Education's estimated revenue per employee is $198,000
Employee Data
- Innopharma Education has 151 Employees.
- Innopharma Education grew their employee count by 34% last year.
Innopharma Education's People
| Name | Title | Email/Phone |
|---|
Innopharma Education Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.3M | 30 | -12% | N/A | N/A |
#2 | $14.8M | 82 | 0% | N/A | N/A |
#3 | $24.1M | 134 | 37% | N/A | N/A |
#4 | $10M | 62 | 15% | N/A | N/A |
#5 | $71.8M | 319 | -4% | N/A | N/A |
#6 | $12M | 74 | 9% | N/A | N/A |
#7 | $32.3M | 163 | 12% | N/A | N/A |
#8 | $12M | 74 | 19% | N/A | N/A |
#9 | $47.1M | 238 | N/A | N/A | N/A |
#10 | $11.8M | 73 | 18% | N/A | N/A |
What Is Innopharma Education?
Innopharma Education deliver third-level qualifications focused on the high-tech manufacturing sector, delivering skills that drive the future of manufacturing forward. The courses run from level 6 certificates through to level 9 masters degrees, covering the pharmaceutical, med-tech and food science industries. We also offer bespoke industry training to pharmaceutical and med-tech companies.
keywords:N/A
N/A
Total Funding
151
Number of Employees
$29.9M
Revenue (est)
34%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Innopharma Education News
... Nua Healthcare, CEC, Resilience, NUI Galway, Innopharma Education, FIT, The Teaching Council, Recruit.ie and Nightcourses.com.
... Nua Healthcare, CEC, Resilience, NUI Galway, Innopharma Education, FIT, The Teaching Council, Recruit.ie and Nightcourses.com.
... NUI Galway, Innopharma Education, The Teaching Council, Recruit.ie, Nightcourses.com and many more. What can you expect at Jobs Expo Galway?
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $48.2M | 151 | 6% | N/A |
#2 | $30.4M | 151 | 26% | N/A |
#3 | $33.3M | 151 | -21% | $160.4M |
#4 | $34.1M | 151 | 8% | N/A |
#5 | $33.9M | 151 | N/A | N/A |